Evidence map›Paper›PMID 38088235›Full record

ArticleEpilepsia2024

Widespread, depth-dependent cortical microstructure alterations in pediatric focal epilepsy.

Chiara Casella, Katy Vecchiato, Daniel Cromb, Yourong Guo, Anderson M Winkler, Emer Hughes, Louise Dillon, Elaine Green, Kathleen Colford, Alexia Egloff and 8 more

Abstract read
In one paragraph

Article in Epilepsia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Chiara CasellaCentre for the Developing Brain, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.ORCID https://orcid.org/0000-0002-0292-3330
Katy VecchiatoCentre for the Developing Brain, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Daniel CrombCentre for the Developing Brain, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Yourong GuoDepartment for Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
Anderson M WinklerDepartment of Human Genetics, University of Texas Rio Grande Valley, Brownsville, Texas, USA.
Emer HughesCentre for the Developing Brain, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Louise DillonCentre for the Developing Brain, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Elaine GreenCentre for the Developing Brain, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Kathleen ColfordCentre for the Developing Brain, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Alexia EgloffCentre for the Developing Brain, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Ata SiddiquiDepartment of Radiology, Guy's and Saint Thomas' Hospitals NHS Trust, London, UK.
Anthony PriceCentre for the Developing Brain, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Lucilio Cordero GrandeDepartment of Biomedical Engineering, King's College London, London, UK.
Tobias C WoodDepartment of Neuroimaging, King's College London, London, UK.
Shaihan MalikDepartment of Biomedical Engineering, King's College London, London, UK.
Rui Pedro A G TeixeiraDepartment of Biomedical Engineering, King's College London, London, UK.
David W CarmichaelDepartment of Biomedical Engineering, King's College London, London, UK.
Jonathan O'MuircheartaighCentre for the Developing Brain, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.

Funding

Medical Research Council MR/K006355/1Medical Research Council MR/LO11530/1Medical Research Council MR/N026063/1Wellcome Trust 206675Wellcome Trust 206675/Z/17/Z
6 · The paper itself

Abstract

objectiveTissue abnormalities in focal epilepsy may extend beyond the presumed focus. The underlying pathophysiology of these broader changes is unclear, and it is not known whether they result from ongoing disease processes or treatment-related side effects, or whether they emerge earlier. Few studies have focused on the period of onset for most focal epilepsies, childhood. Fewer still have utilized quantitative magnetic resonance imaging (MRI), which may provide a more sensitive and interpretable measure of tissue microstructural change. Here, we aimed to determine common spatial modes of changes in cortical architecture in children with heterogeneous drug-resistant focal epilepsy and, secondarily, whether changes were related to disease severity.

methodsTo assess cortical microstructure, quantitative T1 and T2 relaxometry (qT1 and qT2) was measured in 43 children with drug-resistant focal epilepsy (age range = 4-18 years) and 46 typically developing children (age range = 2-18 years). We assessed depth-dependent qT1 and qT2 values across the neocortex, as well as their gradient of change across cortical depths. We also determined whether global changes seen in group analyses were driven by focal pathologies in individual patients. Finally, as a proof-of-concept, we trained a classifier using qT1 and qT2 gradient maps from patients with radiologically defined abnormalities (MRI positive) and healthy controls, and tested whether this could classify patients without reported radiological abnormalities (MRI negative).

resultsWe uncovered depth-dependent qT1 and qT2 increases in widespread cortical areas in patients, likely representing microstructural alterations in myelin or gliosis. Changes did not correlate with disease severity measures, suggesting they may represent antecedent neurobiological alterations. Using a classifier trained with MRI-positive patients and controls, sensitivity was 71.4% at 89.4% specificity on held-out MRI-negative patients. SIGNIFICANCE: These findings suggest the presence of a potential imaging endophenotype of focal epilepsy, detectable irrespective of radiologically identified abnormalities.

Indexed as

Drug Resistant EpilepsyEpilepsies, PartialNeocortexAdolescentChildChild, PreschoolGliosisHumansMagnetic Resonance Imagingcortical microstructureepilepsyfocal cortical dysplasiaMRIrelaxometry

Identifiers

PMID38088235
PMCPMC7616339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.